Posted by AGORACOM-JC
at 4:03 PM on Tuesday, May 4th, 2021
When the Facebook data privacy scandal broke out, the world woke up to just how badly our individual data was being traded, used and most importantly, the amount of profit being generated by major corporations at our expense.
This led to the enactment of the biggest data privacy laws in history. Specifically, General Data Protection Regulation (GDPR) out of Europe and the California Consumer Privacy Act (CCPA).
Enter $LQID. The Company Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.
More than just lip service, $LQID has made some major announcements, including joining the Trust Over IP Foundation, which includes over 170 members including IBM, Mastercard, Accenture and many other global leaders who are defining a complete architecture for Internet-scale digital trust.
Does that sound like a mouthful? Yeah, it does. But all you have to really understand for now is that digital ID, privacy and monetization is going to become a reality in the very near future. Government regulations are enforcing it. Consumers are demanding it and $LQID is delivering it at such an advanced scale that the Trust Over IP Foundation provided them with a strategic role as a Steering Member.
If that wasn’t enough proof for you, Google validated the $LQID business model with this stunning announcement at the beginning of March:
Google believes these types of tracking methods don’t “meet rising consumer expectations for privacy, nor will they stand up to rapidly evolving regulatory restrictions, and therefore aren’t a sustainable long term investment.”
Google is experimenting with tools in its Privacy Sandbox that are designed to allow advertising to continue to work on the web but in a less privacy-encroaching way.
“Keeping the internet open and accessible for everyone requires all of us to do more to protect privacy — and that means an end to not only third-party cookies, but also any technology used for tracking individual people as they browse the web,” David Temkin, Google’s director of product management for ads privacy and trust,
What is the potential outcome of this major shift by Google?
“Google’s decision could upend the ad industry, which has relied on these types of tracking tools”
If consumers are going to switch to Liquid Avatar to protect and monetize their identity, the switch to Digital ID by Canada’s biggest Province is simply a monster catalyst: The Ontario government strategy outlines ways in which it plans to harness the potential of the digital economy and better utilize data. Included in the plan are tangible commitments such as:
the creation of a new data authority;
a new digital artificial intelligence (AI) framework to guide responsible use of AI; and
the introduction of a new government-issued digital ID that lets people prove who they are online.
If you didn’t know any better, you would think CEO David Lucatch wrote the Ontario Digital Strategy paper himself! He didn’t but the next best thing is this interview with CEO David Lucatch for an even deeper discussion into what this all means for $LQID and YOU.
Posted by AGORACOM-JC
at 7:29 PM on Sunday, May 2nd, 2021
Arctic Star $ADD $ASDZF Is exploring for diamonds at its Diagras Property, NWT and are using non-traditional methods to identify Kimberlites they believe host economic diamond potential.
Early success through drilling to date suggests they may have indeed made a discovery at time when very few peers exist while demand for diamonds is increasing. This success supports the overall exploration concept and indicates Arctic may be on to a new method of identifying diamonds.
If you are going to explore for diamonds, you need to look where other mines are with the right geology; and this is where Buddy Doyle comes in to play for Arctic. Buddy made a major discovery in the same area with Rio Tinto and the Diavik mine ( produced over 100 million carats since 2003) and is currently guiding the exploration drilling targeting Non-Magnetics to identify Kimberlite; which Arctic is now 3 for 3 in identifying.
The exploration success Arctic is encountering couldn’t be happening at a better time as the market appears to be waking up to the incredible opportunity Arctic offers. Have a listen and discover why Arctic Star is the next SmallCap discovery.
Posted by AGORACOM-JC
at 7:12 PM on Friday, April 30th, 2021
When it comes to small-cap companies, tech-focused Datametrex AI is in rarefied air; they have not one but two successful independent divisions each capable of being a company maker: COVID-19 test kit distribution, and AI-driven social media monitoring and discovery.
Financial Highlights for year ending December 31, 2020:
Revenue of $12.3M vs. $3.4M for FY 2019
An increase of 264%
We sat down with CEO Marshall Gunter to discuss these highlights, the COVID-19 landscape, telemedicine, 2021 plans, and more.
Posted by AGORACOM-JC
at 6:21 PM on Thursday, April 29th, 2021
What do you get when you combine the leading provider of artificial intelligence driven real-time data insights for brick and mortar retailers, with the global leader in consumer data analytics operating in 100 markets and covering 90% of the world’s population?
Earlier today Loop Insights $MTRX $RACMF and NielsenIQ made this joint announcement that can be summarized by the following excerpt:
“NielsenIQ’s market leading fast-moving consumer goods coverage and Loop’s transformative artificial intelligence solutions present opportunities for collaboration and business development across channels. Retailers will benefit from an enhanced understanding of consumer behavior, thereby boosting personalization, targeting and activation initiatives through the joint power of NielsenIQ and Loop.”
More than just lip service, NielsenIQ is the leader in providing the most complete, unbiased view of consumer behavior, globally. Powered by a ground-breaking consumer data platform and fueled by rich analytic capabilities, NielsenIQ enables decision-making for the world’s leading consumer goods companies and retailers. In short, NielsenIQ measures every consumer transaction to deliver the knowledge that every business needs to drive growth.
If you thought that was powerful, the combination of Loop Insights means that knowledge will be delivered in real-time, something NielsenIQ VP Richard Lee says doesn’t exist in the market today.
How big is this alliance to $MTRX? This quote from CEO Rob Anson says it all:
“The scope, gravity and validation of this agreement with NielsenIQ represent an incredible milestone for Loop and its shareholders. NielsenIQ is the global leader when it comes to measurement and data analytics, as well as providing the most complete and trusted view of the market for leading CPG brands and retailers. In establishing this alliance, Loop is now on a path to achieve global enterprise scale, and has firmly put a stake in the ground as an emerging disruptive player in the world of retail data aggregation and analytics.”
Watch this powerful interview with NielsenIQ VP of Strategic Alliances, Richard Lee and Loop Insights CEO, Rob Anson to learn how they plan to transform the retail sector.
Posted by AGORACOM-JC
at 5:22 PM on Thursday, April 29th, 2021
Valeo Pharma is already a successful, revenue generating, small cap Canadian pharmaceutical company that acquires the Canadian rights to commercialized drugs in other parts of the world that don’t have Canada on their radar as a target market.
This “in-license” business model is ingenious because it means ZERO developmental or clinical risk, which is the downfall of most small cap pharma companies.
This model has resulted in the following success:
2020 net revenues of $7.5 million
2021 is expected to double to $15 million
Commercializing Novartis Asthma Therapies In Canada
Closed $6.6 Million Financing With Insiders Taking ~ 40%
If that was all Valeo had, most investors would be happy to sit back and watch the Company grow.
But then came Redesca. We are going to save you the science and tell you that Redesca belongs to a class of anticoagulant medications (blood thinners) called LMWH. The size of the Canadian LMWH market is over $200M per year and Valeo believes they can capture 15-20% of this market. If you’re doing back of napkin math, that equates to $30,000,000 – $40,000,000 per year in revenues.
But how does a new product capture that much market share? Glad you asked because we asked CEO Steve Saviuk the same question. Competition is tough in all markets and they don’t let someone take 15-20% market share without one hell of a fight. Saviuk agreed and gave the following 3 reasons:
1. Redesca has an 8-year international track record of safety and efficacy. It is already well known
2. Redesca is flat out cheaper, which is music to the ears of Provincial Health Ministries whose budgets have been stretched to the max this year no thanks to COVID-19.
Vaelo is so confident that it stated “This is great news for the Canadian healthcare system …. and is expected to help provide significant savings to provincial healthcare systems.”
More than just lip service, $VPH just announced that Redesca is now listed on the Ontario Public Drug Program, which means the government will cover its costs for all public use. Moreover, $VPH expects additional Provinces to follow.
If you love revenue generating, growing and blue sky potential small cap companies, then this Valeo interview is a must watch.
Posted by AGORACOM-JC
at 4:20 PM on Wednesday, April 28th, 2021
The paradigm shifting, parabolic growth of plant based foods and a plant based life is unstoppable, with the plant-based food market alone expected to reach $74.2 billion by 2027.
With a line up of plant based products and services that includes:
Plant Based Meal Delivery
Plant Based Snack Products
Plant Based Pet foods
Plant Based Restaurant Locator
Plant Based Recipes
Plant Based Essentials …. Like Chocolate (Essential? You Bet)
And …… Plant Based …. PLANTS (It’s A BIG Business!)
If you believe in the massive paradigm shift towards plant based foods and more, be sure to watch and share this great interview with PlantX CEO Julia Frank.
Posted by AGORACOM-JC
at 5:24 PM on Tuesday, April 27th, 2021
HealthSpace Data Systems’ (CSE: HS) (OTCQB: HDSLF) (Frankfurt: 38H) “empowering government efficiency” solution has empowered the firm to become an industry leading tech pioneer, providing both enterprise- and mobile internet-based applications to more than 500 state and local government organizations in North America. Including in:
Sonoma County, California
Jackson County, Missouri
Illinois
Wisconsin
Ontario, Canada
Today, the company announced the planned launch of a new platform, GovCall.
GovCall will be a leading teleconferencing platform focused exclusively on the government market. In order to accomplish this, the Company has entered into an exclusive partnership agreement with Iotum Inc., a leader in teleconferencing and group communications.
HealthSpace currently offers the only integrated product suite to incorporate inspection, administration and analytics across all platforms in North America.
A cloud-based and mobile platform helps revolutionize every aspect of government regulatory work
including licensing and inspections, accounting, even disease surveillance.
And underpinning its innovation is a robust business model:
Scalable with Strong Pipeline of Organic Growth
Fully funded and built to execute on all-time high sales pipeline of >$18m and growing
Sticky and Diversified Customer Base: Over 98% client retention year-over-year
Predictable Recurring Revenues, targeting $10m (Over 100% from YE2020) in Annual Recurring Revenue within 12 to 18 months
HealthSpace CEO Silas Garrison breaks down how GovCall will work and what it will mean for the company:
Posted by AGORACOM-JC
at 7:02 PM on Sunday, April 25th, 2021
Maitri Health Technologies is a global platform for healthcare supply security whose main focus provides a reliable source of certified PPE (personal protective equipment) and testing solutions through an onshore manufacturing model.
This model has led to the creation of innovative and industry leading products including 3D certified surgical masks and patent-pending face shields, all integrated with technology to help track, trace and enable safer workplaces and communities.
It all takes place against a backdrop of huge potential: the global personal protective equipment market size is expected to reach USD 123.38 billion by 2027, registering a CAGR of 9.6%.
After previously securing Health Canada approval for its domestically manufactured N95masks, the company has had a trio of big announcements over the course of the last month:
Maitri has been asked by the British Columbia Ministry of Jobs, Economic Recovery & Innovation to join a government-supported virtual trademission to the United Kingdom.
Andrew McCann, a digital innovator in cloud platforms and online user experiences, and co-founder of DeviantArt, has joined the company as Chief Technology Officer.
Maitri has appointed Bridget Ross, CEO of Israel-based MedTech company ChroniSense Medical, to its Advisory Board.
Andrew Morton, Maitri’s CEO, talks us through the developments:
Posted by AGORACOM-JC
at 4:42 PM on Friday, April 23rd, 2021
HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.
If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:
To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:
“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”
Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated
“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”
Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!
Posted by AGORACOM-JC
at 4:23 PM on Thursday, April 22nd, 2021
Cardiol Therapeutics $CRDL.ca $CRTPF is a groundbreaking, clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular disease (heart/blood vessels).
The company has received approval from the U.S. FDA to commence a Phase II/III, double-blind, placebo-controlled clinical trial investigating the efficacy and safety of its lead clinical product, CardiolRx™, in treating hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease (CVD).
CardiolRx™ is an ultra-pure, high concentration cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP and THC free.
Cardiol is also planning a Phase II international trial of CardiolRx™ in acute myocarditis, a condition caused by inflammation in heart tissue, most common cause of sudden cardiac death in people under 35.
The company is also developing proprietary cannabidiol formulations for the treatment of chronic heart failure.
One such key development is its commercial product, Cortalex™, an extra-strength formulation (100 mg/mL concentration) of cannabidiol oil that is pharmaceutically produced to be free of THC. Cardiol believes Cortalex™ to be the purest form of cannabidiol oil available in Canada.
It is the first THC-free extra-strength formulation of cannabidiol oil available across Canada exclusively online at Medical Cannabis by Canada’s largest pharmacy retailer, Shoppers Drugs Mart.
In March 2020, Cardiol signed a supplier agreement to become a medical cannabidiol supplier to Shoppers Drug Mart. The retailer will supply Cardiol’s pharmaceutical cannabidiol products to Shoppers for sale in all provinces and territories in Canada through Shoppers’ online store, Medical Cannabis by Shoppers.
And there’s plenty more to write home about:
~ $27M from exercise of warrants + equity raise since June 2020
Uplisting to NASDAQ
Team expansion with Chief Medical Officer hire
David Elsley, Cardiol Therapeutics’ President & CEO, gives us the low-down. Check it out:
